| Company | Role | Period | Ownership | Status |
|---|---|---|---|---|
| BioTesch Holding ApS CVR 39660350 | OtherFounder | Since 2018 | — | Active |
| SWAL APS CVR 38360981 | OwnerLegal Owner | Since 2017 | 50.0% | Active |
| Commit Biologics ApS CVR 42642649 | BoardChairman | Since 2023 | — | Active |
| Company | Role | Period | Ownership | Status |
|---|---|---|---|---|
| FTL AF 21/3-2001 A/S CVR 20301295 | BoardBoard of Directors | 2000 – 2001 | — | Dissolved |
| TOPOTARGET A/S CVR 25695771 | BoardBoard of Directors | 2010 – 2014 | — | Dissolved |
| AZIGN BIOSCIENCE A/S CVR 25933354 | BoardBoard of Directors | 2001 – 2001 | — | Dissolved |
| PROLIFERON ApS CVR 26025133 | ManagementChief Executive Officer | 2002 – 2003 | — | Dissolved |
| ONCOTAC PHARMACEUTICALS ApS CVR 26563038 | OtherFounder | 2002 – 2009 | — | Dissolved |
| 3B INVEST ApS CVR 26753120 | BoardBoard of Directors | 2002 – 2004 | — | Dissolved |
| PROLIFERATOR ApS CVR 26878985 | OtherFounder | 2002 – 2015 | — | Dissolved |
| ROS Therapeutics ApS CVR 39507501 | BoardBoard of Directors | 2018 – 2019 | — | Active |
| BioTesch Advice & Consultancy CVR 33228546 | OtherStakeholder | 2011 – 2012 | — | Active |
| ADENIUM BIOTECH ApS CVR 33882785 | BoardBoard of Directors | 2011 – 2015 | — | Dissolved |
| BIOTESCH ADVICE & CONSULTANCY ApS CVR 34600600 | OtherFounder | 2012 – 2015 | — | Dissolved |
| RICC A/S CVR 20690003 | ManagementManagement | 1998 – 2002 | — | Active |
| SANIONA A/S CVR 34049610 | BoardBoard of Directors | 2013 – 2016 | — | Active |
| Servier Symphogen A/S CVR 10013267 | BoardBoard of Directors | 2000 – 2005 | — | Active |
| Antag Therapeutics ApS CVR 38402056 | BoardBoard of Directors | 2017 – 2020 | — | Active |
| Person | Role | Shared companies | Profile |
|---|---|---|---|
| Chief Executive Officer | 2companies | View profile | |
| Management | 2companies | View profile | |
| Chief Executive Officer | 2companies | View profile | |
| Board of Directors | 2companies | View profile | |
| Board of Directors | 2companies | View profile |